Cargando…
Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination
Autores principales: | Butt, Adeel A., Khan, Tasnim, Yan, Peng, Shaikh, Obaid S., Omer, Saad B., Mayr, Florian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159711/ https://www.ncbi.nlm.nih.gov/pubmed/34052241 http://dx.doi.org/10.1016/j.jinf.2021.05.021 |
Ejemplares similares
-
Outcomes among patients with breakthrough SARS-CoV-2 infection after vaccination in a high-risk national population
por: Butt, Adeel A., et al.
Publicado: (2021) -
Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National Population
por: Butt, Adeel A, et al.
Publicado: (2022) -
Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022) -
Risk of SARS-CoV-2 Breakthrough Infection in Vaccinated Cancer Patients: A Retrospective Cohort Study
por: Rooney, Anthony, et al.
Publicado: (2022) -
SARS-CoV-2 breakthrough infections in vaccinated kidney transplant recipients: an issue of concern
por: Wijtvliet, Veerle, et al.
Publicado: (2021)